Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/CRON stock hub

TSX/CRON has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/CRONis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.3B
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/CRON
In the news

Latest news · TSX/CRON

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E47.5
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-0.3
P25 -121.5P50 -40.9P75 0.5
ROIC-5.5
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/CRON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
189
Groups with data
11
Currency
USD
Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
610
Employees Change
151%
Employees Change Percent
32.9
Enterprise value
CAD 234.5M
Exchange
Toronto Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA22717L1013
Last refreshed
2026-05-10
Market cap
CAD 1.3B
Price
CAD 3.47
Price currency
CAD
Rev Per Employee
329,489.13x
Sector
Healthcare
Sic
2834
Symbol
tsx/CRON
Website
https://thecronosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-0.99%
EV Earnings
-18.1x
EV/FCF
1,147.89x
EV/Sales
1.17x
FCF yield
0.02%
Forward P/E
47.53x
P/B ratio
0.83x
P/S ratio
6.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-11.61%
EBITDA Margin
-2.29%
FCF margin
0.1%
Gross margin
39.84%
Gross Profit
CAD 80.1M
Gross Profit Growth
91.59%
Gross Profit Growth Q
79.22%
Gross Profit Growth3 Y
55.82%
Net Income
CAD -13M
Net Income Growth Years
0%
Pretax Margin
-11.68%
Profit Margin
-6.44%
Profit Per Employee
CAD -21,234
ROA
-0.9
Roa5y
-3.85
ROCE
-1.48
ROE
-0.26
Roe5y
-4.78
ROIC
-5.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr10y
30.36%
Cagr1y
35.58%
Cagr3y
8.59%
Cagr5y
-18%
EPS Growth Years
0
FCF Growth
-97.68%
FCF Growth Q
132.13%
OCF Growth
37.27%
OCF Growth Q
53.3%
Revenue Growth
24.63x
Revenue Growth Q
46.96x
Revenue Growth Quarters
10x
Revenue Growth Years
2x
Revenue Growth3 Y
19.11x
Revenue Growth5 Y
25.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CAD 0.12
Assets
CAD 1.6B
Cash
CAD 1.1B
Current Assets
CAD 1.3B
Current Liabilities
CAD 65.9M
Debt
CAD 2.1M
Debt Equity
CAD 0
Debt FCF
CAD 10.13
Equity
CAD 1.6B
Liabilities
CAD 74.3M
Long Term Assets
CAD 350.8M
Long Term Liabilities
CAD 8.4M
Net Cash
CAD 1.1B
Net Cash By Market Cap
CAD 87.19
Net Cash Growth
-3.09%
Net Debt Equity
CAD -0.73
Net Debt FCF
CAD -5,572
Tangible Book Value
CAD 1.4B
Tangible Book Value Per Share
CAD 3.66
WACC
11.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
19.59
Inventory Turnover
2.21
Net Working Capital
CAD 88.4M
Quick ratio
18.45
Working Capital
CAD 1.2B
Working Capital Turnover
CAD 0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
1,316.33%
1Y total return
35.55%
200-day SMA
3.55
3Y total return
28.04%
50-day SMA
3.56
50-day SMA vs 200-day SMA
50over200
5Y total return
-62.93%
All Time High
32.95
All Time High Change
-89.47%
All Time High Date
2019-02-04
All Time Low
0.14
All Time Low Change
2,378.57%
All Time Low Date
2016-05-17
ATR
0.14
Beta
1.23
Beta1y
1.57
Beta2y
1.36
Ch YTD
-3.61
High
3.58
High52
4.66
High52 Date
2025-12-15
High52ch
-25.54%
Low
3.46
Low52
2.54
Low52 Date
2025-06-23
Low52ch
36.61%
Ma50ch
-2.42%
Price vs 200-day SMA
-2.12%
RSI
42.79
RSI Monthly
51.31
RSI Weekly
48.39
Sharpe ratio
0.8x
Sortino ratio
1.51
Total Return
0.54%
Tr YTD
-3.61
Tr1m
-0.86%
Tr1w
-3.88%
Tr3m
-3.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -23.3M
Operating margin
-11.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
194,910,022%
Shares Insiders
6.59%
Shares Institutions
15.03%
Shares Out
376,271,333
Shares Qo Q
-0.64%
Shares Yo Y
-0.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
CAD -9.5M
Average Volume
193,885.7x
Bv Per Share
3.93
CAPEX
CAD -35.3M
Ch10y
1,316.3
Ch1m
-0.86
Ch1w
-3.88
Ch1y
35.55
Ch3m
-3.61
Ch3y
28.04
Ch5y
-62.93
Change
-1.42%
Change From Open
-1.7
Close
3.52
Days Gap
0.28
Depreciation Amortization
18,676,637.1
Dollar Volume
595,462.4
Earnings Date
2026-05-11
EBIT
CAD -23.3M
EBITDA
CAD -4.6M
EPS
CAD -0.03
F Score
5
FCF
CAD 204,297
FCF EV Yield
0.09x
FCF Per Share
CAD 0
Financing CF
-27,292,144
Fiscal Year End
December
Founded
2,012
Goodwill
90,878,749.9
Income Tax
CAD -19.5M
Investing CF
-104,971,576
Is Primary Listing
1
Last Earnings Date
2026-02-27
Last Report Date
2025-12-31
Ma150
3.59
Ma150ch
-3.42%
Ma20
3.63
Ma20ch
-4.49%
Net CF
-91,880,122
Next Earnings Date
2026-05-11
Open
3.53
P FCF Ratio
6,391
P OCF Ratio
36.82
Position In Range
8.33
Ppne
201,348,693.4
Price Date
2026-05-08
Ptbv Ratio
0.93
Relative Volume
0.89x
Revenue
200,988,367x
SBC By Revenue
4.81x
Share Based Comp
9,666,396
Tax By Revenue
-9.68x
Volume
171,603
Z Score
10.8
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/CRON pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/CRON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+35.5%
S&P 500 1Y: n/a
3Y total return
+28.0%
S&P 500 3Y: n/a
5Y total return
-62.9%
S&P 500 5Y: n/a
10Y total return
+1316.3%
S&P 500 10Y: n/a
Ownership

Who owns TSX/CRON?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.0%
Share of float held by funds and institutions
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.5%
Negative means the company is buying back shares.
Technical

TSX/CRON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.8
Neutral momentum band
Price vs 200-day MA
-2.1%
50/200-day relationship not available
Beta (5Y)
1.23
More volatile than the market
Sharpe ratio
0.80
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/CRON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/CRON stock rating?

tsx/CRON is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/CRON analysis?

The full report lives at /stocks/tsx/CRON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/CRON?

The latest report frames tsx/CRON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/CRON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.